These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 894031)

  • 1. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
    Ralph P; Nakoinz I
    J Immunol; 1977 Sep; 119(3):950-54. PubMed ID: 894031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic functions and in vitro activation of cultured macrophage tumor lines.
    Ralph P; Nakoinz I; Broxmeyer HE; Schrader S
    Natl Cancer Inst Monogr; 1978 May; (48):303-10. PubMed ID: 107454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids block newly induced but not constitutive functions of macrophage cell lines: myeloid colony-stimulating activity production, latex phagocytosis, and antibody-dependent lysis of RBC and tumor targets.
    Ralph P; Ito M; Broxmeyer HE; Nakoinz I
    J Immunol; 1978 Jul; 121(1):300-3. PubMed ID: 670703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
    Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
    Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
    Gardner CR; Wasserman AJ; Laskin DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes.
    Ralph P; Nakoinz I; Diamond B; Yelton D
    J Immunol; 1980 Nov; 125(5):1885-8. PubMed ID: 7430616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
    Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
    J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
    Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
    Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML; Domzig W; Taskov H
    Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
    Berke G; McVey E; Hu V; Clark WR
    J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.